- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05359471
Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLD (Theratech)
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This is single center, cross sectional study conducted at the Chronic Viral Illness Service (CVIS) of McGill University Health Center (MUHC). This is a pilot feasibility study with the aim of further exploring more options to conduct or facilitate similar studies in larger group.. The investigator will correlate visceral fat with simple clinical parameters, including BMI and waist circumference and comparing measures of visceral fat between PLHIV with and without NAFLD. Participants will undergo a single study visit for confirmation of eligibility.
Until now, there has been no study assessing the distribution of visceral fat in PLHIV with NAFLD by clinical anthropometric indicators (WHR), lipid accumulation product (waist circumference, hip circumference and waist to hip ratio and triglycerides) and radiological techniques such as DXA. In the present feasibility pilot study, the investigator will determine the distribution of excessive fat around the abdomen(visceral fat) by DXA scan in HIV mono-infected patients with/without NAFLD to see if it will be possible to conduct a larger study.. The investigator will also correlate visceral fat with simple clinical parameters, including BMI and waist circumference and comparing measures of visceral fat between PLHIV with and without NAFLD.
DXA scan Bone densitometry, also called dual-energy x-ray absorptiometry, DEXA or DXA, uses a very small dose of ionizing radiation to produce pictures of the inside of the body (usually the lower (or lumbar) spine and hips) to measure bone loss. It is commonly used to diagnose osteoporosis, to assess an individual's risk for developing osteoporotic fractures. DXA is simple, quick and noninvasive. It's also the most commonly used and the most standard method for diagnosing osteoporosis.
Primary Objective
In order to determine if the distribution of visceral fat in PLHIV with NAFLD by clinical anthropometric indicators (waist-to-hip ratio), lipid accumulation product (waist circumference and triglycerides) and radiological techniques such as DXA (trunk fat mass and fat mass through dual-energy X-ray absorptiometry) could be used in future larger study groups.
Secondary Objectives
- To correlate visceral fat with simple clinical parameters, including BMI and waist circumference.
- To compare measures of visceral fat between PLHIV with and without NAFLD.
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Quebec
-
Montreal, Quebec, Canada
- McGill University Health center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age ≥18 years old at screening;
- Able to provide informed consent, in French or English;
- Historical HIV seropositive (ELISA with Western blot confirmation);
Exclusion Criteria
- Contraindications to Fibroscan with CAP (pregnant women or individuals carrying a pacemaker);
- Historical evidence of co-infection with Hepatitis B or C (i.e. HBsAg or anti-HCV positive);
- Significant alcohol intake (>21 units/week in men and >14 units/week in women[23]) at screening using the Alcohol Use Disorders Identification Test (AUDIT-C) questionnaire;
- Patients with previous decompensating events from liver cirrhosis (Child-Pugh B and C), hepatocellular carcinoma, liver transplantation.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Ricerca sui servizi sanitari
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: HIV with NAFLD
HIV Nonalcoholic fatty liver disease patients
|
It is the standard method for diagnosing osteoporosis.
In the central DXA examination, which measures bone density of the hip and spine, the patient lies on a padded table.
Altri nomi:
Smoking and drug related questionnaires will be used as variable to see dependence, how it impacts participants activities/health or determining whether they are light/moderate/heavy smoker
History of previous liver diseases including hepatitis B, C, and HIV
|
Comparatore attivo: HIV without NAFLD
HIV without Nonalcoholic fatty liver disease patients
|
It is the standard method for diagnosing osteoporosis.
In the central DXA examination, which measures bone density of the hip and spine, the patient lies on a padded table.
Altri nomi:
Smoking and drug related questionnaires will be used as variable to see dependence, how it impacts participants activities/health or determining whether they are light/moderate/heavy smoker
History of previous liver diseases including hepatitis B, C, and HIV
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Determination of visceral fat
Lasso di tempo: Through study completion, an average of 1 year
|
Outcome Measures The primary outcome is the presence of high visceral fat, defined as >35% total body fat for females and >25% total body fat for males.
|
Through study completion, an average of 1 year
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2021-6656
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Bone densitometry
-
Institut Straumann AGAttivo, non reclutante
-
University of Maryland, BaltimoreNational Institute of Nursing Research (NINR)CompletatoOsteoporosi | Comportamenti sanitari
-
Institut Straumann AGCompletatoMascella, Edentulo, ParzialmenteSpagna, Germania, Stati Uniti, Australia, Italia, Svezia, Svizzera
-
Krishnadevaraya College of Dental Sciences & HospitalCompletato
-
Institut Straumann AGCompletato
-
Abyrx, Inc.TerminatoSpondilite anchilosante | Vertebre fuse | Deformità sagittali | Cifosi toracolombareStati Uniti
-
California State University, NorthridgeCompletato
-
Clalit Health ServicesSconosciutoValutazione dell'età ossea mediante tecnologia ad ultrasuoniIsraele
-
Institut Straumann AGCompletatoMascella, Edentulo, ParzialmenteRegno Unito
-
University of Campinas, BrazilCompletatoMalattia parodontaleBrasile